| dc.contributor.author | Topuz, Erkan | |
| dc.contributor.author | Tas, Faruk | |
| dc.contributor.author | Soydinc, Hilal O. | |
| dc.contributor.author | Selam, Meltem | |
| dc.contributor.author | Yasasever, Vildan | |
| dc.contributor.author | Cicin, Irfan | |
| dc.contributor.author | Duranyildiz, Derya | |
| dc.contributor.author | Disci, Rian | |
| dc.contributor.author | Uygun, Kazim | |
| dc.date.accessioned | 2021-03-06T20:29:41Z | |
| dc.date.available | 2021-03-06T20:29:41Z | |
| dc.date.issued | 2008 | |
| dc.identifier.citation | Tas F., Duranyildiz D., Soydinc H. O. , Cicin I., Selam M., Uygun K., Disci R., Yasasever V., Topuz E., "Effect of maximum-tolerated doses and low-dose metronomic chemotherapy on serum vascular endothelial growth factor and thrombospondin-1 levels in patients with advanced nonsmall cell lung cancer", CANCER CHEMOTHERAPY AND PHARMACOLOGY, cilt.61, ss.721-725, 2008 | |
| dc.identifier.issn | 0344-5704 | |
| dc.identifier.other | av_fa6c75cf-3413-4dfa-ab21-2ecb3f0af607 | |
| dc.identifier.other | vv_1032021 | |
| dc.identifier.uri | http://hdl.handle.net/20.500.12627/163971 | |
| dc.identifier.uri | https://doi.org/10.1007/s00280-007-0526-4 | |
| dc.description.abstract | Background Angiogenesis is regulated by a balance of both angiogenic inducers and inhibitors. This study was designed to evaluate the effect of both maximum-tolerated doses (MTD) and low-dose metronomic chemotherapy (LDM) on serum vascular endothelial growth factor (VEGF), thrombospondin-1 (TSP1) and VEGFR1 concentrations in patients with advanced nonsmall cell lung cancer. | |
| dc.language.iso | eng | |
| dc.subject | Life Sciences | |
| dc.subject | Health Sciences | |
| dc.subject | Oncology | |
| dc.subject | ONKOLOJİ | |
| dc.subject | Klinik Tıp | |
| dc.subject | Klinik Tıp (MED) | |
| dc.subject | FARMAKOLOJİ VE ECZACILIK | |
| dc.subject | Farmakoloji ve Toksikoloji | |
| dc.subject | Yaşam Bilimleri (LIFE) | |
| dc.subject | Tıp | |
| dc.subject | Sağlık Bilimleri | |
| dc.subject | Dahili Tıp Bilimleri | |
| dc.subject | İç Hastalıkları | |
| dc.subject | Onkoloji | |
| dc.subject | Eczacılık | |
| dc.subject | Temel Eczacılık Bilimleri | |
| dc.subject | Yaşam Bilimleri | |
| dc.subject | Temel Bilimler | |
| dc.subject | Pharmacology | |
| dc.subject | General Pharmacology, Toxicology and Pharmaceutics | |
| dc.subject | Pharmacology, Toxicology and Pharmaceutics (miscellaneous) | |
| dc.subject | Pharmacology (medical) | |
| dc.subject | Pharmacy | |
| dc.subject | Drug Guides | |
| dc.title | Effect of maximum-tolerated doses and low-dose metronomic chemotherapy on serum vascular endothelial growth factor and thrombospondin-1 levels in patients with advanced nonsmall cell lung cancer | |
| dc.type | Makale | |
| dc.relation.journal | CANCER CHEMOTHERAPY AND PHARMACOLOGY | |
| dc.contributor.department | İstanbul Üniversitesi , , | |
| dc.identifier.volume | 61 | |
| dc.identifier.issue | 5 | |
| dc.identifier.startpage | 721 | |
| dc.identifier.endpage | 725 | |
| dc.contributor.firstauthorID | 7332 | |